Q13351 (KLF1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 114.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Krueppel-like factor 1 Alternative name(s): Erythroid krueppel-like transcription factor Short name=EKLF | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 362 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Transcription regulator of erythrocyte development that probably serves as a general switch factor during erythropoiesis. Is a dual regulator of fetal-to-adult globin switching. Binds to the CACCC box in the beta-globin gene promoter and acts as a preferential activator of this gene. Furthermore, it binds to the BCL11A promoter and activates expression of BCL11A, which in turn represses the HBG1 and HBG2 genes. This dual activity ensures that, in most adults, fetal hemoglobin levels are low. Able to activate CD44 and AQP1 promoters. When sumoylated, acts as a transcriptional repressor by promoting interaction with CDH2/MI2beta and also represses megakaryocytic differentiation By similarity. Ref.6 Ref.7 |
| Subunit structure | Interacts with CBP and EP300; the interactions enhance the transactivation activity. Interacts with PCAF; the interaction does not acetylate EKLF and inhibits its transactivation activity By similarity. Ref.5 |
| Subcellular location | Nucleus. Note: Colocalizes with SUMO1 in nuclear speckles By similarity. Ref.6 |
| Tissue specificity | Expression restricted to adult bone marrow and fetal liver. Not expressed in myeloid nor lymphoid cell lines. Ref.1 Ref.2 |
| Post-translational modification | Acetylated; can be acetylated on both Lys-274 and Lys-288. Acetylation on Lys-274 (by CBP) appears to be the major site affecting EKLF transactivation activity By similarity. Sumoylated; sumoylation, promoted by PIAS1, leads to repression of megakaryocyte differentiation. Also promotes the interaction with the CDH4 subunit of the NuRD repression complex By similarity. Phosphorylated primarily on serine residues in the transactivation domain. Phosphorylation on Thr-23 is critical for the transactivation activity By similarity. |
| Polymorphism | Genetic variations in KLF1 underlie the fetal hemoglobin quantitative trait locus 6 (HBFQTL6) [MIM:613566]. Classic hereditary persistence of fetal hemoglobin (HPFH) is characterized by a substantial elevation of fetal hemoglobin (HbF) in adult red blood cells. There are no other phenotypic or hematologic manifestations. In healthy adults, fetal hemoglobin (HbF) is present at residual levels (less than 0.06% of total hemoglobin) with over 20-fold variation. Ten to fifteen percent of adults fall within the upper tail of the distribution. Genetic variations in KLF1 underlie the blood group-Lutheran inhibitor (In(Lu)) phenotype [MIM:111150]; also known as dominant Lu (a-b-) phenotype. In(Lu) is characterized phenotypically by the apparent absence of the Lu antigen (BCAM) on red blood cells during serologic tests: Lu(a-b-). |
| Involvement in disease | Congenital dyserythropoietic anemia 4 (CDA4) [MIM:613673]: A blood disorder characterized by ineffective erythropoiesis and hemolysis resulting in anemia. Circulating erythroblasts and erythroblasts in the bone marrow show various morphologic abnormalities. Affected individuals with CDA4 also have increased levels of fetal hemoglobin. |
| Sequence similarities | Belongs to the krueppel C2H2-type zinc-finger protein family. Contains 3 C2H2-type zinc fingers. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||
Molecule processing | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 362 | 362 | Krueppel-like factor 1 | PRO_0000047160 | |||||||||
Regions | |||||||||||||
| Zinc finger | 279 – 303 | 25 | C2H2-type 1 | ||||||||||
| Zinc finger | 309 – 333 | 25 | C2H2-type 2 | ||||||||||
| Zinc finger | 339 – 361 | 23 | C2H2-type 3 | ||||||||||
| Compositional bias | 1 – 263 | 263 | Pro-rich | ||||||||||
| Compositional bias | 61 – 76 | 16 | Asp/Glu-rich (acidic) | ||||||||||
Amino acid modifications | |||||||||||||
| Modified residue | 23 | 1 | Phosphothreonine; by CK2 Probable | ||||||||||
| Modified residue | 274 | 1 | N6-acetyllysine By similarity | ||||||||||
| Modified residue | 288 | 1 | N6-acetyllysine By similarity | ||||||||||
| Cross-link | 54 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) By similarity | |||||||||||
Natural variations | |||||||||||||
| Natural variant | 102 | 1 | S → P. Ref.4 Ref.6 Corresponds to variant rs2072597 [ dbSNP | Ensembl ]. | VAR_043981 | |||||||||
| Natural variant | 182 | 1 | F → L. Corresponds to variant rs2072596 [ dbSNP | Ensembl ]. | VAR_043982 | |||||||||
| Natural variant | 299 | 1 | H → Y in blood group-In(Lu). Ref.8 | VAR_058108 | |||||||||
| Natural variant | 325 | 1 | E → K in CDA4; has a dominant-negative effect on the transcriptional activation of CD44 and AQP1 promoters. Ref.6 | VAR_064901 | |||||||||
| Natural variant | 328 | 1 | R → H in blood group-In(Lu). Ref.8 | VAR_058109 | |||||||||
| Natural variant | 328 | 1 | R → L in blood group-In(Lu). Ref.8 | VAR_058110 | |||||||||
| Natural variant | 331 | 1 | R → G in blood group-In(Lu). Ref.8 | VAR_058111 | |||||||||
Experimental info | |||||||||||||
| Sequence conflict | 163 | 1 | A → G in AAC51108. Ref.2 | ||||||||||
| Sequence conflict | 173 | 1 | P → A in AAC51108. Ref.2 | ||||||||||
| Sequence conflict | 184 | 1 | R → G in AAC51108. Ref.2 | ||||||||||
| Sequence conflict | 192 | 1 | A → E in AAC51108. Ref.2 | ||||||||||
Secondary structure | |||||||||||||
Helix Strand Turn | |||||||||||||
| Beta strand | 64 – 67 | 4 | |||||||||||
| Beta strand | 70 – 75 | 6 | |||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Isolation, genomic structure, and expression of human erythroid Kruppel-like factor (EKLF)." Bieker J.J. DNA Cell Biol. 15:347-352(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY. |
| [2] | "The human erythroid-specific transcription factor EKLF localizes to chromosome 19p13.12-p13.13." van Ree J.H., Roskrow M.A., Becher A.M., McNall R., Valentine V.A., Jane S.M., Cunningham J.M. Genomics 39:393-395(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY. |
| [3] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT PRO-102. Tissue: Lung. |
| [5] | "Acetylation and modulation of erythroid Krueppel-like factor (EKLF) activity by interaction with histone acetyltransferases." Zhang W., Bieker J.J. Proc. Natl. Acad. Sci. U.S.A. 95:9855-9860(1998) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION, INTERACTION WITH CBP; EP300 AND PCAF. |
| [6] | "A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia." Arnaud L., Saison C., Helias V., Lucien N., Steschenko D., Giarratana M.C., Prehu C., Foliguet B., Montout L., de Brevern A.G., Francina A., Ripoche P., Fenneteau O., Da Costa L., Peyrard T., Coghlan G., Illum N., Birgens H. Cartron J.P.Am. J. Hum. Genet. 87:721-727(2010) [PubMed] [Europe PMC] [Abstract] Cited for: ROLE IN ERYTHROPOIESIS, FUNCTION AS TRANSCRIPTIONAL ACTIVATOR OF CD44 AND AQP1, SUBCELLULAR LOCATION, VARIANT PRO-102, VARIANT CDA4 LYS-325, CHARACTERIZATION OF VARIANT CDA4 LYS-325. |
| [7] | "Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin." Borg J., Papadopoulos P., Georgitsi M., Gutierrez L., Grech G., Fanis P., Phylactides M., Verkerk A.J., van der Spek P.J., Scerri C.A., Cassar W., Galdies R., van Ijcken W., Ozgur Z., Gillemans N., Hou J., Bugeja M., Grosveld F.G. Philipsen S.Nat. Genet. 42:801-805(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION AS REGULATOR OF FETAL-TO-ADULT GLOBIN SWITCHING, INVOLVEMENT IN HBFQTL6. |
| [8] | "Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype." Singleton B.K., Burton N.M., Green C., Brady R.L., Anstee D.J. Blood 112:2081-2088(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS BLOOD GROUP-IN(LU) TYR-299; LEU-328; HIS-328 AND GLY-331. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U37106 Genomic DNA. Translation: AAC50562.1. U65404 mRNA. Translation: AAC51108.1. AD000092 Genomic DNA. Translation: AAB51173.1. BC033580 mRNA. Translation: AAH33580.1. | ||||||||||||
| IPI | IPI00012816. | ||||||||||||
| PIR | T45072. | ||||||||||||
| RefSeq | NP_006554.1. NM_006563.3. | ||||||||||||
| UniGene | Hs.37860. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q13351. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-43776N. | ||||||||||||
| MINT | MINT-1891495. | ||||||||||||
| STRING | 9606.ENSP00000264834. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q13351. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 2501699. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q13351. | ||||||||||||
| PRIDE | Q13351. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000264834; ENSP00000264834; ENSG00000105610. | ||||||||||||
| GeneID | 10661. | ||||||||||||
| KEGG | hsa:10661. | ||||||||||||
| UCSC | uc002mvo.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 10661. | ||||||||||||
| GeneCards | GC19M012995. | ||||||||||||
| HGNC | HGNC:6345. KLF1. | ||||||||||||
| HPA | HPA051850. | ||||||||||||
| MIM | 111150. phenotype. 600599. gene. 613566. phenotype. 613673. phenotype. | ||||||||||||
| neXtProt | NX_Q13351. | ||||||||||||
| Orphanet | 293825. Congenital dyserythropoietic anemia due to KLF1 mutation. 46532. Hereditary persistence of fetal hemoglobin - beta-thalassemia. 251380. Hereditary persistence of fetal hemoglobin - sickle cell disease. | ||||||||||||
| PharmGKB | PA30131. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG5048. | ||||||||||||
| HOGENOM | HOG000060173. | ||||||||||||
| HOVERGEN | HBG006220. | ||||||||||||
| InParanoid | Q13351. | ||||||||||||
| KO | K09204. | ||||||||||||
| OMA | QYQGHFQ. | ||||||||||||
| OrthoDB | EOG48SGTT. | ||||||||||||
| PhylomeDB | Q13351. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q13351. | ||||||||||||
| Bgee | Q13351. | ||||||||||||
| CleanEx | HS_KLF1. | ||||||||||||
| Genevestigator | Q13351. | ||||||||||||
| GermOnline | ENSG00000105610. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 3.30.160.60. 3 hits. | ||||||||||||
| InterPro | IPR007087. Znf_C2H2. IPR015880. Znf_C2H2-like. IPR013087. Znf_C2H2/integrase_DNA-bd. [Graphical view] | ||||||||||||
| SMART | SM00355. ZnF_C2H2. 3 hits. [Graphical view] | ||||||||||||
| PROSITE | PS00028. ZINC_FINGER_C2H2_1. 3 hits. PS50157. ZINC_FINGER_C2H2_2. 3 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | Q13351. | ||||||||||||
| GenomeRNAi | 10661. | ||||||||||||
| NextBio | 40543. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | KLF1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q13351 Secondary accession number(s): Q6PIJ5, Q92899 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
